Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2 Open-Label Study to Evaluate Safety and Clinical Activity of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Next Previous
X
Search
Trial Profile

A Phase 2 Open-Label Study to Evaluate Safety and Clinical Activity of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Etavopivat (Primary)
  • Indications Alpha-thalassaemia; Beta-thalassaemia; Sickle cell anaemia
  • Focus Therapeutic Use
  • Acronyms 4202-HEM-201; Gladiolus
  • Sponsors FORMA Therapeutics; Novo Nordisk

    • Most Recent Events

    • 10 Dec 2023 Planned End Date changed from 31 Jul 2025 to 1 Dec 2025.
    • 10 Dec 2023 Planned primary completion date changed from 30 Mar 2025 to 3 Nov 2025.
    • 05 Aug 2022 According to a FORMA Therapeutics media release, results are expected by year-end.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top